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Short Communication
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Abstract
The serotonergic system has been hypothesized to contribute to the biological susceptibility to type 2 diabetes
mellitus (T2DM) and body-mass index (BMI) categories. We investigate a possible association of 5-HTTLPR polymorphism (L and S alleles) in the promoter region of the serotonin transporter gene (SLC6A4) with the development
of T2DM and/or higher BMI by analyzing a sample of 138 individuals diagnosed with T2DM and 172 unrelated controls from the Mexican general population. In the total sample genotypes were distributed according to HardyWeinberg equilibrium, and S allele frequency was 0.58. There was no statistical association between 5-HTTLPR
polymorphism and the development of T2DM in this Mexican population sample (p = 0.12). Nevertheless, logistic regression analysis of the L allele and increased BMI disclosed an association, after adjusting for age, sex and T2DM
(p = 0.02, OR 1.74, 95% CI: 1.079-2.808).
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Over the last three decades, the rates of overweight,
obesity, and type 2 diabetes mellitus (T2DM) have increased worldwide (Ogden et al., 2006; Fuemmeler et al.,
2009;). Specifically, and with a rising prevalence of 10.6%,
Mexico is among the top 10 countries with the highest number of diabetic individuals (6.1 million) (Rull et al., 2005;
Gonzalez-Villalpando et al., 2010) where it has also been
reported that the combined prevalence of overweight and
obesity is 63% among Mexicans (Arroyo et al., 2000;
Fernald et al., 2004). Obesity and T2DM frequently
co-occur, indicating that these conditions share common
pathological mechanisms, including complex interactions
Send correspondence to Valeria Peralta-Leal. Facultad de Medicina e Ingeniería en Sistemas Computacionales, Avenida Sendero
Nacional km 3, C.P. 87380. H Matamoros, Tamaulipas, México.
E-Mail: valeriaperaltaleal@yahoo.com.mx.
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between genetic and environmental factors (Knowler et al.,
1993). In the search for genetic factors that confer susceptibility to obesity and T2DM, several candidate genes have
been identified (Prokopenko et al., 2008; Yang et al.,
2007). Due to their function in the brain and gastrointestinal
tract, genes of the serotonergic system are included among
these. Serotonin (5-hydroxytryptamine or 5-HT) is involved in the regulation of energy balance through central
modulation of the activity of various downstream neuropeptide systems, as well as autonomic pathways (Iordanidou et al., 2010). Some functional effects of 5-HT include
mood control, urine storage, voiding, sleep regulation,
body temperature, circadian functions, feeding behavior,
body weight, and intestinal motility (Lesch et al., 1996; Ni
and Watts, 2006; Sookoian et al., 2008). It is well established that 5-HT activity is regulated by the 5-HT transporter (5-HTT), whose functions include 5-HT re-uptake in
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serotonergic nerve terminals, thereby determining the magnitude and duration of postsynaptic response to 5-HT, and
signaling quantity (Lesch and Mossner, 1998).
The human 5-HTT is encoded by the serotonin transporter gene (SLC6A4) on chromosome 17, at 17q11.217q12 (Lesch et al., 1996). Located at 1,400 bp upstream of
the transcription start site of the gene, a functional polymorphism has been described, the SLC6A4-linked polymorphic
region or 5-HTTLPR (Collier et al., 1996; Heils et al.,
1996). This consists of two common alleles, i.e., a short (S)
variant with 14 copies, and a long (L) variant with 16 copies
of a 44 bp repeat element (Lesch et al., 1996; Kraft et al.,
2005). The S allele (SS or SL genotypes) is associated with
lower SLC6A4 expression, thereby resulting in reduced
5-HT reuptake and release capability, whereas the L variant
is associated with an almost threefold increase in gene transcription (Iordanidou et al., 2010). Association studies of
5-HTTLPR with glucose metabolism, changes in the
body-mass index (BMI) and T2DM are relatively recent. In
a longitudinal study of Japanese women, analysis of the association of SLC6A4 polymorphism with fasting blood glucose (FBG) levels indicated that the SS genotype plays a
protective role, thereby improving FBG values (Yamakawa
et al., 2005). Meanwhile, in one of the largest cohorts studied to date, involving, 1,584 unrelated individuals, a
subsample of the US National Longitudinal Study of Adolescent Health, Fuemmeler et al. (2008) found that SS and
SL 5-HTTLPR genotypes are significantly associated with
a higher BMI, for men overall, and for Hispanic men and
those of European ancestry, specifically. This association
was further confirmed in South American population samples of adolescents and adults of European ancestry, in
which the S allele was found to be a risk factor (Sookoian et
al., 2007, 2008). So far, in only one study has reported the S
allele as a risk factor for T2DM, in a Caucasian population
from Greece, interestingly, the presence of the S allele was
not found to be associated with increased BMI values
(Iordanidou et al., 2010).
The aim of the present study was to investigate
whether there was an association of the 5-HTTLPR polymorphism of the SLC6A4 gene with T2DM or BMI (as a
measure of obesity) in a Mexican population sample.
A total of 138 unrelated subjects diagnosed with
T2DM (42 males and 96 females) and 172 unrelated controls (48 males and 124 females) from Mexican general
population were studied. All individuals were recruited at
the Hospital “Secretaria de Salud, Hospital General de
Reynosa, Dr. Jose Maria Cantu Garza” Tamaulipas, Mexico. Inclusion of subjects in the diabetic group was based on
medical diagnosis, according to the criteria recommended
by the WHO for T2DM (Deckers et al., 2006). Subjects
with either diagnosis or a first-degree family history of type
T2DM were excluded from the control sample. BMI was
calculated as the ratio between weight and the square of the
height (kg/m2). Subjects were also divided into over-
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weight/obese (BMI > 25) and non-obese (BMI < 25)
groups. The study protocol for human experimentation was
previously approved by the local ethics committee
(PROMEP/103.5/08/3243). Informed consent was obtained from each subject before participation in the study.
Genomic DNA was isolated from peripheral blood
for genotyping, according to Gustincich et al. (1991). Polymerase Chain Reaction (PCR) for 5-HTTLPR polymorphism genotyping was performed as previously described
Cook et al. (1997),with minor modifications. The forward
primer
used
was
HTTp2A,
5’-TGAATGCCAGCACCTAACCC-3’, and the reverse
primer HTTp2B, 5’-TTCTGGTGCCACCTAGACGC-3’.
The final amplicon product consisted of 406/450-bp fragments (S and L alleles, respectively). PCR was carried out
in a total volume of 25 mL containing 200 mM of each dNTP
(dATP, dCTP, and dTTP), 100 mM of dGTP and 7-deazadGTP, 1 unit of Taq polymerase (High Fidelity;
Invitrogen), 1.5 mM of MgSO4, 5% DMSO, and 10 mM of
Tris-HCl. Amplification was carried out in a Thermal
Cycler C1000 System through 40 cycles consisting of 30 s
at 95 °C, 30 s at 61 °C, and 1 min at 71 °C, followed by
10 min at 72 °C. PCR products were separated by electrophoresis on a 6% polyacrylamide gel at 120 V for 3 h.
Bands were visualized using a silver nitrate staining protocol. Subjects were classified into three genotypes: individuals homozygous for the short allele SS, those heterozygous
for the short and long allele LS, and those homozygous for
the long allele LL.
Data are shown as means and ± standard deviation
(SD). Deviation from Hardy-Weinberg equilibrium was
confirmed by X2–test analysis of genotype distribution. The
association between 5-HTTLPR and T2DM|BMI, as an
obesity|overweight measure, was defined by logisticregression analysis, assuming an additive model. Considering gender, age and T2DM as the appropriate
covariates, associations were adjusted accordingly. The
odds ratios (ORs) with 95% confidence intervals (CIs) are
presented in the tables with respect to the risk allele. A P
value of 0.05 was considered significant. Statistical analysis was performed using PLINK version 1.07 (Purcell et al.,
2007), and SPSS version 17.0 (SPSS, Chicago, IL, USA).
Quanto Software version 1.2.4 (Gauderman and Morrison,
2006) was used for calculating the power of the sample. On
considering 10.6% diabetes prevalence among Mexican individuals (Rull et al., 2005), a frequency of 42% for the analyzed polymorphism and an additive genetic model,
allowed to estimate that the sample size of the present study
had an 80% power at an alpha of 0.05 to detect an effect size
of 1.6.
Gender distribution among the 310 participants was
71% females and 29% males. According to the WHO criteria for diagnosis, 138 individuals had T2DM (44.5%),
whereas 172 were non-diabetic (55.5%). The distribution
of BMI, according to WHO classification and differences
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Table 3 - Logistic regression analysis of the association between T2DM
and the L allele of the SLC6A4 5-HTTLPR polymorphism.

between subgroups, are shown in Table 1. Genotype distribution of the SLC6A4 gene among the analyzed groups is
shown in Table 2. 5-HTLPR polymorphism was found to
be in Hardy-Weinberg equilibrium in the total sample
(p = 0.24). Although logistic regression analysis indicated
no statistically significant association of the 5-HTTLPR
polymorphism with T2DM (p = 0.17), BMI was shown to
be a discrete predictor of T2DM in the Mexican population
(Table 3). This same association was found when BMI was
analyzed as a continuous variable under the linear regression model (p = 0.03, 1.874 [0.1336-3.615]). The L allele
was associated with overweight/obesity BMI values by logistic regression analysis (p = 0.02; 1.74 [1.079-2.808])
(Table 4), independent of age, gender or T2DM.
The high prevalence and increasing number of Mexicans suffering from obesity and T2DM represent a huge
burden on healthcare (Mier et al., 2008; Gonzalez-Villalpando et al., 2010), whence the prime importance of identifying risk factors for susceptibility to these conditions. The
Mexican population we investigated showed a statistical
difference in age distribution between the diabetic and
non-diabetic groups, as expected, since T2DM is a chronic
condition increasing in prevalence, as the population ages.
As previously shown (Iordanidou et al., 2010), our analysis
confirmed BMI as a discrete predictor of T2DM. Although
described in Caucasians (Iordanidou et al., 2010), in the

Covariates

OR

95% CI

p

L allele

0.7375

(0.5022-1.083)

0.12

Age

1.062

(1.041-1.084)

< 0.001*

Gender

0.8936

(0.5094-1.568)

0.69

BMI(kg/m2)

1.048

(1.008-1.09)

0.01*

Model Adjusted by Age, Sex and BMI.
* = Statistically significant.
Table 4 - Logistic regression analysis of the association between overweight and the L allele of the SLC6A4 5-HTTLPR polymorphism.
Covariates

OR

95% CI

p

L allele

1.74

(1.079-2.808)

0.02*

Age

1.012

(0.9924-1.032)

0.23

Gender

1.292

(0.6948-2.404)

0.41

T2DM

2.415

(1.284-4.543)

0.006*

Model Adjusted by Age, Sex and T2DM.
* = Statistically significant.

present Mexican population sample, no association between 5-HTTLPR polymorphism of the SLC6A4 gene and
T2DM was detected. Nonetheless, frequency of the previ-

Table 1 - Characteristics of the analyzed groups.
Phenotypes

Non-diabetic group n = 172

Diabetic group n = 138

p

BMI < 25 n = 69

BMI > 25n = 217

p*

Age (Years)

45 ± 16.5

54 ± 10.8

< 0.001*

46 ± 17.36

50.40 ± 13.55

0.05

48 (28%)/124 (72%)

42 (30%)/96 (70%)

Gender (M/F)

21 (30%)/48 (70%) 60 (27%)/157 (73%)

Presence of T2DM
BMI > 25
Body weight (kg)
2

BMI (kg/m )

31%

52%

69%

84%

70.06 ± 16.40

74.87 ± 16.13

0.003*

56.74 ± 8.25

77.89 ± 14.33

< 0.001*

26.92 ± 10.2

28.6 ± 6.8

0.06

22.63 ± 1.7

31.12 ± 4.6

< 0.001*

Values are mean ± SD.
* = Statistically significant.

Table 2 - Genotype and allele frequencies of the SLC6A4 5-HTTLPR polymorphism in the analyzed groups.
5-HTTLPR
polymorphism

Phenotypes
Non-Diabetic Group

Diabetic Group

Total

BMI < 25

BMI > 25

Total

n (%)

n (%)

n (%)

n (%)

n (%)

n (%)

LL

33 (20)

16 (12)

49 (16)

7 (11)

37 (18)

44 (16)

LS

88 (51)

74 (53)

162 (52)

35 (50)

118 (54)

153 (53)

SS

51 (29)

48 (35)

99 (32)

27 (39)

62 (28)

89 (31)

L

154 (45)

106 (39)

260 (42)

49 (36)

192 (45)

241 (42)

S

190 (55)

170 (61)

360 (58)

89 (64)

242 (55)

331 (58)

Genotypes

Alleles
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ously reported T2DM risk allele S was higher. Increased
frequencies of the S allele have already been reported in
Native American, Japanese, Chinese and Korean populations the highest frequencies, even reaching 80% (Goldman
et al., 2010). On analyzing BMI values, with adjustment of
age, gender and T2DM as covariates, the role of T2DM as a
predictor of obesity was clearly shown (Table 4). While
Yamakawa et al. (2005) reported that the S allele was protective, as regards FBS levels, our results showed a direct
association of the L allele with increased BMI, independent
of age, gender or T2DM. These results differ from those reported by Sookoian et al. (2007, 2008), showing the S allele
to be a risk factor for higher BMI among adolescent and
adult men from Argentina, as is also shown by Fuemmeler
et al. (2008) in Caucasian and Hispanic adolescents from
the U.S.A. Nonetheless, all these studies are in agreement
by pointing out that SLC6A4 polymorphism is associated
with BMI, and ethnicity may be a contributing factor towards the differences between our study and previous reports. From a functional perspective and through in vitro
studies, it is assumed that the L allele is associated with relatively increased SLC6A4 transcription, thereby resulting
in increased transporter levels and more rapid 5-HT uptake
(Lesch et al., 1996; Greenberg et al., 1999), whence the inference that there may be a reduction in extracellular serotonin among LL homozygous carriers (Glenn, 2011). In
contrast to the L allele, it has been shown that the S allele
is associated with lower transcriptional activity and reduced 5-HT reuptake efficiency (Heils et al., 1996).
Hence, it can be tentatively argued that patients with SS or
SL genotypes have greater availability of 5-HT at their
central serotonergic synapses, thereby intensifying satiety
and reducing food intake, and so inducing lower BMI and
decreased fat mass (Monteleone et al., 2006). Interestingly, in animal models and humans, an increase in 5-HT
levels leads to eating less, whereas a decrease in 5-HT activity precipitates compulsive or binge eating (Blundell,
1986).
Due to the relatively small number of subjects in this
study, Type II error, through the lack of observed association between the analyzed polymorphism and T2DM, cannot be ruled out. Further analysis with a larger sample is
warranted. Another limitation in this preliminary study was
the paucity of additional phenotypes investigated, such as
insulin and lipid levels, and other relevant clinical measurements. Since the Mexican population resulted from an admixture of Native Americans and Europeans (Spanish)
with a smaller contribution from African groups, the probability of population stratification cannot be ruled out. Nevertheless, the information reported in this preliminary
investigation is relevant, because of the high impact of obesity as a health problem in Mexico. In addition, the allele
frequencies of SLC6A4 polymorphism determined in this
population sample constitute a useful reference for genetic
studies.
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